Thomsen-Friedenreich antigen activation as a predictor for clinical outcome of pediatric patients with invasive pneumococcal disease
The most severe form of pneumococcal disease is invasive pneumococcal disease (IPD), including empyema, sepsis and meningitis. Thomsen-Friedenreich antigen (TA; Gal β1-3GalNAc) activation is known to be a predictor of Streptococcus pneumoniae-associated hemolytic uremic syndrome (Sp-HUS). There have been limited data to correlate TA activation and overall disease severity of IPD in children. The study aimed to prove the positive correlation between TA activati on and disease severity and to demonstrate the trend of TA level during the disease course.
Source: Pediatrics and Neonatology - Category: Perinatology & Neonatology Authors: Yi-Ching Chen, Hsin-Hang Chen, Rajendra-Prasad Janapatla, Anna Dudek, Mei-Hua Hsu, Chyi-Liang Chen, Cheng-Hsun Chiu Tags: Original Article Source Type: research
More News: Children | Hemolytic Uremic Syndrome (HUS) | Men | Meningitis | Pediatrics | Perinatology & Neonatology | Study